{"id":26275,"date":"2025-11-05T11:38:34","date_gmt":"2025-11-05T17:38:34","guid":{"rendered":"https:\/\/conexionnacional.mx\/?p=26275"},"modified":"2025-11-05T11:38:40","modified_gmt":"2025-11-05T17:38:40","slug":"vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk","status":"publish","type":"post","link":"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/","title":{"rendered":"Vacuna para prevenir VIH podr\u00eda llegar el pr\u00f3ximo a\u00f1o a M\u00e9xico: GSK"},"content":{"rendered":"\n<p>En una conversaci\u00f3n con medios, GSK M\u00e9xico revel\u00f3 los avances m\u00e1s recientes en investigaci\u00f3n cl\u00ednica, destacando su compromiso con el&nbsp;<strong>desarrollo de medicamentos innovadores para VIH y c\u00e1ncer,<\/strong>&nbsp;dos de sus principales \u00e1reas terap\u00e9uticas.<\/p>\n\n\n\n<p>La compa\u00f1\u00eda se\u00f1al\u00f3 que M\u00e9xico se perfila como uno de los mercados m\u00e1s importantes de Am\u00e9rica Latina para la investigaci\u00f3n y comercializaci\u00f3n de f\u00e1rmacos de alta especialidad.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"https:\/\/www.excelsior.com.mx\/660x495\/filters:format(webp):quality(75)\/\/media\/inside-the-note\/pictures\/2025\/11\/05\/vacuna-vih.jpg\" alt=\"Imagen intermedia\" class=\"lazyload\" title=\"Imagen Intermedia\"\/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><\/h3>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Terapias m\u00e1s duraderas para el VIH<\/strong><\/h2>\n\n\n\n<p>El doctor Sigfrido Rangel, director m\u00e9dico de GSK M\u00e9xico, explic\u00f3 que la empresa se ha consolidado como una de las pioneras mundiales en el tratamiento del VIH.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>Fuimos la primera compa\u00f1\u00eda en desarrollar la zidovudina para tratar el virus en la d\u00e9cada de los ochenta\u201d, record\u00f3.<\/p>\n<\/blockquote>\n\n\n\n<p>Hoy, la farmac\u00e9utica trabaja en esquemas simplificados de dos medicamentos, dise\u00f1ados para reducir la toxicidad y los efectos secundarios a largo plazo.&nbsp;<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>Durante muchos a\u00f1os se combinaban tres f\u00e1rmacos; ahora, con dos, logramos la misma potencia terap\u00e9utica con menos riesgo para el paciente\u201d, se\u00f1al\u00f3 Rangel.<\/p>\n<\/blockquote>\n\n\n\n<p>El siguiente paso en la estrategia de GSK son los medicamentos de larga duraci\u00f3n, que buscan reemplazar el tratamiento diario por aplicaciones m\u00e1s espaciadas.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>Estamos por lanzar en M\u00e9xico una nueva opci\u00f3n inyectable que se aplicar\u00e1 cada dos meses. En lugar de tomar pastillas todos los d\u00edas, el paciente podr\u00e1 recibir seis inyecciones al a\u00f1o y mantener la supresi\u00f3n del virus\u201d, detall\u00f3 el directivo.<\/p>\n<\/blockquote>\n\n\n\n<p>Adem\u00e1s, esta tecnolog\u00eda tambi\u00e9n se utilizar\u00e1 en la prevenci\u00f3n del VIH, ofreciendo protecci\u00f3n mediante inyecciones bimestrales para quienes se encuentran en riesgo de infecci\u00f3n.&nbsp;<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>Los resultados de los estudios cl\u00ednicos son positivos, y el lanzamiento se prev\u00e9 para mediados del pr\u00f3ximo a\u00f1o\u201d, agreg\u00f3.<\/p>\n<\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\"><img fetchpriority=\"high\" decoding=\"async\" width=\"660\" height=\"495\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"https:\/\/www.excelsior.com.mx\/660x495\/filters:format(webp):quality(75)\/\/media\/inside-the-note\/pictures\/2025\/11\/05\/vacuna-vih_2.jpg\" class=\"lazyload\" alt=\"Imagen intermedia\"><\/h2>\n\n\n\n<h2 class=\"wp-block-heading\">Innovaci\u00f3n en oncolog\u00eda y enfermedades cr\u00f3nicas<\/h2>\n\n\n\n<p>Junto con los avances en VIH, GSK report\u00f3 un crecimiento significativo en su \u00e1rea de oncolog\u00eda, donde mantiene una amplia cartera de medicamentos en desarrollo.&nbsp;<\/p>\n\n\n\n<p>Actualmente, la empresa cuenta con&nbsp;<strong>90 productos en investigaci\u00f3n cl\u00ednica, la mayor\u00eda en fases 2 y 3, enfocados en c\u00e1ncer de endometrio, mieloma m\u00faltiple, enfermedades respiratorias graves<\/strong>&nbsp;como EPOC y asma, y padecimientos autoinmunes como el lupus.<\/p>\n\n\n\n<p>El director m\u00e9dico subray\u00f3 que la oncolog\u00eda es uno de los pilares estrat\u00e9gicos de GSK en M\u00e9xico.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>Estamos trayendo mucha innovaci\u00f3n al \u00e1rea de c\u00e1ncer y colaborando con instituciones p\u00fablicas para que los pacientes tengan acceso a tratamientos m\u00e1s eficaces y seguros\u201d, afirm\u00f3.<\/p>\n<\/blockquote>\n\n\n\n<p>Entre los pr\u00f3ximos hitos, la farmac\u00e9utica anunci\u00f3 la realizaci\u00f3n del primer estudio cl\u00ednico fase 1 en una instituci\u00f3n p\u00fablica mexicana, aprobado por COFEPRIS.&nbsp;<br>M\u00e9xico como centro de innovaci\u00f3n biom\u00e9dica<\/p>\n\n\n\n<p>De acuerdo con Rangel,&nbsp;<strong>GSK invertir\u00e1 alrededor de 120 millones de pesos anuales en investigaci\u00f3n cl\u00ednica en M\u00e9xico,<\/strong>&nbsp;cifra que la compa\u00f1\u00eda planea quintuplicar en los pr\u00f3ximos cinco a\u00f1os. El objetivo es fortalecer la infraestructura cient\u00edfica local y consolidar al pa\u00eds como l\u00edder regional en investigaci\u00f3n m\u00e9dica.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>Tenemos un gran potencial: contamos con instituciones de salud s\u00f3lidas, m\u00e9dicos capacitados y pacientes dispuestos a participar. M\u00e9xico podr\u00eda convertirse en el mercado n\u00famero uno de Am\u00e9rica Latina en investigaci\u00f3n cl\u00ednica\u201d, afirm\u00f3 el especialista.<\/p>\n<\/blockquote>\n\n\n\n<p>La empresa tambi\u00e9n impulsa programas de educaci\u00f3n m\u00e9dica continua junto a universidades y sociedades cient\u00edficas, con el prop\u00f3sito de mantener actualizados a los profesionales de la salud sobre los avances terap\u00e9uticos y promover una atenci\u00f3n m\u00e1s eficiente y personalizada.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>En una conversaci\u00f3n con medios, GSK M\u00e9xico revel\u00f3 los avances m\u00e1s recientes en investigaci\u00f3n cl\u00ednica, destacando su compromiso con el&nbsp;desarrollo de medicamentos innovadores para VIH y c\u00e1ncer,&nbsp;dos de sus principales \u00e1reas terap\u00e9uticas. La compa\u00f1\u00eda se\u00f1al\u00f3 que M\u00e9xico se perfila como uno de los mercados m\u00e1s importantes de Am\u00e9rica Latina para la investigaci\u00f3n y comercializaci\u00f3n de [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":26276,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"aside","meta":{"googlesitekit_rrm_CAowytPeCw:productID":"","footnotes":""},"categories":[3],"tags":[2495],"class_list":["post-26275","post","type-post","status-publish","format-aside","has-post-thumbnail","hentry","category-nacional","tag-vih","post_format-post-format-aside"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vacuna para prevenir VIH podr\u00eda llegar el pr\u00f3ximo a\u00f1o a M\u00e9xico: GSK |<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vacuna para prevenir VIH podr\u00eda llegar el pr\u00f3ximo a\u00f1o a M\u00e9xico: GSK |\" \/>\n<meta property=\"og:description\" content=\"En una conversaci\u00f3n con medios, GSK M\u00e9xico revel\u00f3 los avances m\u00e1s recientes en investigaci\u00f3n cl\u00ednica, destacando su compromiso con el&nbsp;desarrollo de medicamentos innovadores para VIH y c\u00e1ncer,&nbsp;dos de sus principales \u00e1reas terap\u00e9uticas. La compa\u00f1\u00eda se\u00f1al\u00f3 que M\u00e9xico se perfila como uno de los mercados m\u00e1s importantes de Am\u00e9rica Latina para la investigaci\u00f3n y comercializaci\u00f3n de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/\" \/>\n<meta property=\"og:site_name\" content=\"Conexi\u00f3n Nacional\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cnmxradio\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-05T17:38:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-05T17:38:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/conexionnacional.mx\/wp-content\/uploads\/2025\/11\/3411675.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"770\" \/>\n\t<meta property=\"og:image:height\" content=\"530\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Redacci\u00f3n Conexi\u00f3n\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redacci\u00f3n Conexi\u00f3n\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/index.php\\\/2025\\\/11\\\/05\\\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/index.php\\\/2025\\\/11\\\/05\\\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\\\/\"},\"author\":{\"name\":\"Redacci\u00f3n Conexi\u00f3n\",\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/#\\\/schema\\\/person\\\/ba9cbd742badd9e3d29f2973a1391d18\"},\"headline\":\"Vacuna para prevenir VIH podr\u00eda llegar el pr\u00f3ximo a\u00f1o a M\u00e9xico: GSK\",\"datePublished\":\"2025-11-05T17:38:34+00:00\",\"dateModified\":\"2025-11-05T17:38:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/index.php\\\/2025\\\/11\\\/05\\\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\\\/\"},\"wordCount\":641,\"publisher\":{\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/index.php\\\/2025\\\/11\\\/05\\\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/conexionnacional.mx\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/3411675.jpg\",\"keywords\":[\"VIH\"],\"articleSection\":[\"Nacional\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/index.php\\\/2025\\\/11\\\/05\\\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\\\/\",\"url\":\"https:\\\/\\\/conexionnacional.mx\\\/index.php\\\/2025\\\/11\\\/05\\\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\\\/\",\"name\":\"Vacuna para prevenir VIH podr\u00eda llegar el pr\u00f3ximo a\u00f1o a M\u00e9xico: GSK |\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/index.php\\\/2025\\\/11\\\/05\\\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/index.php\\\/2025\\\/11\\\/05\\\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/conexionnacional.mx\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/3411675.jpg\",\"datePublished\":\"2025-11-05T17:38:34+00:00\",\"dateModified\":\"2025-11-05T17:38:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/index.php\\\/2025\\\/11\\\/05\\\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/conexionnacional.mx\\\/index.php\\\/2025\\\/11\\\/05\\\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/index.php\\\/2025\\\/11\\\/05\\\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\\\/#primaryimage\",\"url\":\"https:\\\/\\\/conexionnacional.mx\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/3411675.jpg\",\"contentUrl\":\"https:\\\/\\\/conexionnacional.mx\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/3411675.jpg\",\"width\":770,\"height\":530},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/index.php\\\/2025\\\/11\\\/05\\\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/conexionnacional.mx\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vacuna para prevenir VIH podr\u00eda llegar el pr\u00f3ximo a\u00f1o a M\u00e9xico: GSK\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/#website\",\"url\":\"https:\\\/\\\/conexionnacional.mx\\\/\",\"name\":\"Conexi\u00f3n Nacional\",\"description\":\"Noticias al momento\",\"publisher\":{\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/#organization\"},\"alternateName\":\"Noticias nacionales\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/conexionnacional.mx\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/#organization\",\"name\":\"Conexi\u00f3n Nacional\",\"url\":\"https:\\\/\\\/conexionnacional.mx\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/conexionnacional.mx\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/conexion_nacional.png\",\"contentUrl\":\"https:\\\/\\\/conexionnacional.mx\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/conexion_nacional.png\",\"width\":2964,\"height\":1173,\"caption\":\"Conexi\u00f3n Nacional\"},\"image\":{\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/cnmxradio\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/conexionnacional.mx\\\/#\\\/schema\\\/person\\\/ba9cbd742badd9e3d29f2973a1391d18\",\"name\":\"Redacci\u00f3n Conexi\u00f3n\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8d9ed9913523aff42c4fa3d2fdc52c4dfb8c185dc3f4126ecf97512ec86caa63?s=96&d=blank&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8d9ed9913523aff42c4fa3d2fdc52c4dfb8c185dc3f4126ecf97512ec86caa63?s=96&d=blank&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8d9ed9913523aff42c4fa3d2fdc52c4dfb8c185dc3f4126ecf97512ec86caa63?s=96&d=blank&r=g\",\"caption\":\"Redacci\u00f3n Conexi\u00f3n\"},\"url\":\"https:\\\/\\\/conexionnacional.mx\\\/index.php\\\/author\\\/rafael\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vacuna para prevenir VIH podr\u00eda llegar el pr\u00f3ximo a\u00f1o a M\u00e9xico: GSK |","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/","og_locale":"es_MX","og_type":"article","og_title":"Vacuna para prevenir VIH podr\u00eda llegar el pr\u00f3ximo a\u00f1o a M\u00e9xico: GSK |","og_description":"En una conversaci\u00f3n con medios, GSK M\u00e9xico revel\u00f3 los avances m\u00e1s recientes en investigaci\u00f3n cl\u00ednica, destacando su compromiso con el&nbsp;desarrollo de medicamentos innovadores para VIH y c\u00e1ncer,&nbsp;dos de sus principales \u00e1reas terap\u00e9uticas. La compa\u00f1\u00eda se\u00f1al\u00f3 que M\u00e9xico se perfila como uno de los mercados m\u00e1s importantes de Am\u00e9rica Latina para la investigaci\u00f3n y comercializaci\u00f3n de [&hellip;]","og_url":"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/","og_site_name":"Conexi\u00f3n Nacional","article_publisher":"https:\/\/www.facebook.com\/cnmxradio","article_published_time":"2025-11-05T17:38:34+00:00","article_modified_time":"2025-11-05T17:38:40+00:00","og_image":[{"width":770,"height":530,"url":"https:\/\/conexionnacional.mx\/wp-content\/uploads\/2025\/11\/3411675.jpg","type":"image\/jpeg"}],"author":"Redacci\u00f3n Conexi\u00f3n","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Redacci\u00f3n Conexi\u00f3n","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/#article","isPartOf":{"@id":"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/"},"author":{"name":"Redacci\u00f3n Conexi\u00f3n","@id":"https:\/\/conexionnacional.mx\/#\/schema\/person\/ba9cbd742badd9e3d29f2973a1391d18"},"headline":"Vacuna para prevenir VIH podr\u00eda llegar el pr\u00f3ximo a\u00f1o a M\u00e9xico: GSK","datePublished":"2025-11-05T17:38:34+00:00","dateModified":"2025-11-05T17:38:40+00:00","mainEntityOfPage":{"@id":"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/"},"wordCount":641,"publisher":{"@id":"https:\/\/conexionnacional.mx\/#organization"},"image":{"@id":"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/#primaryimage"},"thumbnailUrl":"https:\/\/conexionnacional.mx\/wp-content\/uploads\/2025\/11\/3411675.jpg","keywords":["VIH"],"articleSection":["Nacional"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/","url":"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/","name":"Vacuna para prevenir VIH podr\u00eda llegar el pr\u00f3ximo a\u00f1o a M\u00e9xico: GSK |","isPartOf":{"@id":"https:\/\/conexionnacional.mx\/#website"},"primaryImageOfPage":{"@id":"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/#primaryimage"},"image":{"@id":"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/#primaryimage"},"thumbnailUrl":"https:\/\/conexionnacional.mx\/wp-content\/uploads\/2025\/11\/3411675.jpg","datePublished":"2025-11-05T17:38:34+00:00","dateModified":"2025-11-05T17:38:40+00:00","breadcrumb":{"@id":"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/#primaryimage","url":"https:\/\/conexionnacional.mx\/wp-content\/uploads\/2025\/11\/3411675.jpg","contentUrl":"https:\/\/conexionnacional.mx\/wp-content\/uploads\/2025\/11\/3411675.jpg","width":770,"height":530},{"@type":"BreadcrumbList","@id":"https:\/\/conexionnacional.mx\/index.php\/2025\/11\/05\/vacuna-para-prevenir-vih-podria-llegar-el-proximo-ano-a-mexico-gsk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/conexionnacional.mx\/"},{"@type":"ListItem","position":2,"name":"Vacuna para prevenir VIH podr\u00eda llegar el pr\u00f3ximo a\u00f1o a M\u00e9xico: GSK"}]},{"@type":"WebSite","@id":"https:\/\/conexionnacional.mx\/#website","url":"https:\/\/conexionnacional.mx\/","name":"Conexi\u00f3n Nacional","description":"Noticias al momento","publisher":{"@id":"https:\/\/conexionnacional.mx\/#organization"},"alternateName":"Noticias nacionales","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/conexionnacional.mx\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/conexionnacional.mx\/#organization","name":"Conexi\u00f3n Nacional","url":"https:\/\/conexionnacional.mx\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/conexionnacional.mx\/#\/schema\/logo\/image\/","url":"https:\/\/conexionnacional.mx\/wp-content\/uploads\/2022\/09\/conexion_nacional.png","contentUrl":"https:\/\/conexionnacional.mx\/wp-content\/uploads\/2022\/09\/conexion_nacional.png","width":2964,"height":1173,"caption":"Conexi\u00f3n Nacional"},"image":{"@id":"https:\/\/conexionnacional.mx\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cnmxradio"]},{"@type":"Person","@id":"https:\/\/conexionnacional.mx\/#\/schema\/person\/ba9cbd742badd9e3d29f2973a1391d18","name":"Redacci\u00f3n Conexi\u00f3n","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8d9ed9913523aff42c4fa3d2fdc52c4dfb8c185dc3f4126ecf97512ec86caa63?s=96&d=blank&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8d9ed9913523aff42c4fa3d2fdc52c4dfb8c185dc3f4126ecf97512ec86caa63?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8d9ed9913523aff42c4fa3d2fdc52c4dfb8c185dc3f4126ecf97512ec86caa63?s=96&d=blank&r=g","caption":"Redacci\u00f3n Conexi\u00f3n"},"url":"https:\/\/conexionnacional.mx\/index.php\/author\/rafael\/"}]}},"_links":{"self":[{"href":"https:\/\/conexionnacional.mx\/index.php\/wp-json\/wp\/v2\/posts\/26275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/conexionnacional.mx\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/conexionnacional.mx\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/conexionnacional.mx\/index.php\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/conexionnacional.mx\/index.php\/wp-json\/wp\/v2\/comments?post=26275"}],"version-history":[{"count":1,"href":"https:\/\/conexionnacional.mx\/index.php\/wp-json\/wp\/v2\/posts\/26275\/revisions"}],"predecessor-version":[{"id":26277,"href":"https:\/\/conexionnacional.mx\/index.php\/wp-json\/wp\/v2\/posts\/26275\/revisions\/26277"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/conexionnacional.mx\/index.php\/wp-json\/wp\/v2\/media\/26276"}],"wp:attachment":[{"href":"https:\/\/conexionnacional.mx\/index.php\/wp-json\/wp\/v2\/media?parent=26275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/conexionnacional.mx\/index.php\/wp-json\/wp\/v2\/categories?post=26275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/conexionnacional.mx\/index.php\/wp-json\/wp\/v2\/tags?post=26275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}